Select Language
CD45
CD45 Overview
| English Name | Leukocyte common antigen | Approved Drugs | 0 |
| Drugs in Clinical Trials | 3 | Target Synonym | PTPRC，T200，CD45，Protein Tyrosine Phosphatase， Receptor Type C，CD45 Antigen，L-CA，Protein Tyrosine Phosphatase， Receptor Type， C Polypeptide，Receptor-Type Tyrosine-Protein Phosphatase C，T200 Leukocyte Common Antigen，Leukocyte Common Antigen，T200 Glycoprotein，EC 3.1.3.48，CD45R，GP180，B220，LCA，LY5，Leukocyte Common Antigens，Protein Tyrosine Phosphatase Receptor Type C，EC:3.1.3.48 |
| Highest Development Stage | Phase 3 Clinical | ||
| English Name | Leukocyte common antigen |
| Target Synonym | PTPRC，T200，CD45，Protein Tyrosine Phosphatase， Receptor Type C，CD45 Antigen，L-CA，Protein Tyrosine Phosphatase， Receptor Type， C Polypeptide，Receptor-Type Tyrosine-Protein Phosphatase C，T200 Leukocyte Common Antigen，Leukocyte Common Antigen，T200 Glycoprotein，EC 3.1.3.48，CD45R，GP180，B220，LCA，LY5，Leukocyte Common Antigens，Protein Tyrosine Phosphatase Receptor Type C，EC:3.1.3.48 |
| Approved Drugs | 0 |
| Drugs in Clinical Trials | 3 |
| Highest Development Stage | Phase 3 Clinical |
CD45 Product List
- Product Category
Protein (5)Antibody (3)
- Product Status
Launched (8)
- Species
Human (4)Mouse (4)
- Tag
His Tag & Avi Tag (2)His Tag (2)Llama IgG Fc Tag (1)Mouse IgG2a (1)- (2)
- Conjugate
Biotin-labeled (2)Unconjugated (3)PerCP-Cy5.5 Labeled (2)PE Labeled (1)
Add to Cart
Total: 8
- 1
CD45 Background
CD45 is a receptor protein tyrosine phosphatase, also known as Ly-5 or leukocyte common antigen. CD45 mainly involves in the initiation of T cell receptor signaling by controlling the activation of the Src family protein-tyrosine kinases Lck and Fyn. CD45 deficiency causes in T- and B-lymphocyte dysfunction in the form of severe combined immune deficiency. It also takes a significant role in autoimmune diseases and cancer as well as in infectious diseases including fungal infections.
CD45 Synonyms
CD45,PTPRC,L-CA,T200
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Immunomodulatory progenitor cell therapy (Celixir) | Phase 3 Clinical | Celixir | Endomyocardial Fibrosis; Cardiomyopathies | Details | |
| I-131-Apamistamab | BC8-I-131; BC-8; 131IBC8 | Phase 3 Clinical | Fred Hutchinson Cancer Research Center | Neoplasms, Gonadal Tissue; Lymphoma, Mantle-Cell; Sezary Syndrome; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Lymphoma; Burkitt Lymphoma; Intraocular Lymphoma; Lymphoma, T-Cell; Lymphoma, Follicular; Waldenstrom Macroglobulinemia; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Anemia, Sideroblastic; Angioimmunoblastic T-cell Lymphoma; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Mycosis Fungoides; Leukemia-Lymphoma, Adult T-Cell; Leukemia; Lymphoma, B-Cell, Marginal Zone; Lymphoma, T-Cell, Peripheral; Hematopoietic stem cell transplantation (HSCT); Neoplastic Cells, Circulating; Leukemia, Hairy Cell; Anemia, Refractory, with Excess of Blasts; Lymphoma, Large B-Cell, Diffuse; Lymphoma, B-Cell; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Hodgkin Disease; Lymphoma, Large-Cell, Immunoblastic; Lymphomatoid Granulomatosis; Lymphoma, Extranodal NK-T-Cell; Pancytopenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Details |
| At 211 MAb BC8-B10 | Phase 2 Clinical | Fred Hutchinson Cancer Research Center | Neoplasms | Details |
Product Reviews
N***o2023-05-13
0People LikeWe were very satisfied with the whole process of purchasing and utilizing the product as we had no issues with shipping time or product packaging. We used the protein to assist in the development of LFAs detecting for CD45 on cells. Pairs of anti-CD45 antibodies were first tested using the protein to help us determine which pair of antibodies produced the best results. These tests allowed us to move forward with designing full LFAs.- L***h2021-12-13 1People LikeDear Sir or Madam,_x000D_ I had an overall good service from Acro Biosystems._x000D_ Shipment was fast and product quality was good._x000D_ Got the protocol for QC after asking the customer service._x000D_ Protocol for QC was easy to understand and repeat._x000D_ Easy way to download the Certificate of Analysis via the printed QR code on product vials._x000D_ Customer service answered very fast and was very friendly._x000D_ QC of biotinylated human CD45 protein vs. Human Galectin-1 protein (GA1-H4113) was fine._x000D_ Biotinylated human CD45 protein worked fine and could be loaded on Streptavidin biosensors (Octet system).
- Overview
- Product List
- Product Reviews
- Clinical Drug Information
Share to:
Online Message
[North America]: 1 Innovation Way, Newark, DE 19711, USA [Switzerland]: Switzerland Innovation Park Basel Area, Novartis Campus, Lichtstrasse 35, 4056 Basel
Email：order@acrobiosystems.com
Copyright © 2025 ACROBiosystems. All Rights Reserved
Contact Us
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland